profit from every IDR 100 of sales.
IDR 0IDR 100
PT Famon Awal Bros Sedaya Tbk
IDR 715.00+5.15% today
-20.1% in 1 year
1-year low IDR 605.001-year high IDR 895.00
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay IDR 47.21 for every IDR 1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
PT Famon Awal Bros Sedaya Tbk vs. similar companies
PT Famon Awal Bros Sedaya Tbk grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from IDR 100 of sales | Sales growth a year | Price per IDR 1 of profit |
|---|---|---|---|
| PT Famon Awal Bros Sedaya Tbk | 47.2× · Expensive | ||
 HCA Healthcare | 15.4× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.9× · Fair price | ||
 IHH Healthcare Berhad | 34.3× · Expensive | ||
 Rede D'Or São Luiz | 16.2× · Fair price |
AI analysis
An AI analyst reads PT Famon Awal Bros Sedaya Tbk's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 47.2×
- –
- 1.01
- 2.9×
- 4.1×
- –
- –
- -4.0%
- 2.1%
- –
Profitability
- 28.0%
- 10.8%
- 8.7%
- –
- 5.6%
- 5.3%
- –
- –
- –
- –
Growth
- +17.0%
- +46.8%
- –
- –
- +2.3%
Financial health
- 3.3×
- 0.60
- –
- 4.6×
- 1.65
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 49%of 952
Top 46%of 884
Bottom 25%of 601
Top 32%of 886
Bottom 20%of 987
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
28No pass
Benjamin Graham
35No pass
Philip Fisher
40No pass
Peter Lynch
82Pass
Joel Greenblatt
5No pass
Charlie Munger
16No pass
Terry Smith
15No pass
Questions about PT Famon Awal Bros Sedaya Tbk
Is PT Famon Awal Bros Sedaya Tbk a good stock to buy?
A business with weak numbers, but the price is high. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the PT Famon Awal Bros Sedaya Tbk AI analysis
What does PT Famon Awal Bros Sedaya Tbk do?
PT Famon Awal Bros Sedaya Tbk operates a network of hospitals in Indonesia. The company offers mother and child center, heart and vascular center, trauma center, cancer center, urology center, brain and neurocenter, eye center, and sports clinic, and orthopedic center. It is in Medical Care Facilities.
Is PT Famon Awal Bros Sedaya Tbk stock halal?
Yes. PT Famon Awal Bros Sedaya Tbk passes our halal screen: its business is permitted and its debt is 19% of its market value, under the 30% limit. How we check
How has PT Famon Awal Bros Sedaya Tbk stock done over the past year?
Down 20.1% over the past twelve months, to IDR 715.00. It traded between IDR 605.00 and IDR 895.00 and is 20.1% below its high.
Who are PT Famon Awal Bros Sedaya Tbk's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with PT Famon Awal Bros Sedaya Tbk's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.